Nomura Holdings
ADVM

Nomura Holdings’s Adverum Biotechnologies ADVM Stock Holding History

Nomura Holdings’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-18,912
Closed -$332K – 1940
2021
Q4 		$332K Buy
+18,912
New +$379K ﹤0.01% 1648
2020
Q4 		– Sell
-3,200
Closed -$334K – 1503
2020
Q3 		$334K Buy
3,200
+2,172
+211% +$325K ﹤0.01% 1092
2020
Q2 		$214K Sell
1,028
-4,872
-83% -$863K ﹤0.01% 989
2020
Q1 		$585K Buy
+5,900
New +$688K ﹤0.01% 642

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nomura Holdings's ADVM Position: Q1 2022 in Review

Nomura Holdings sold out of Adverum Biotechnologies (ADVM) in Q1 2022, closing a stake of 18,912 shares — an estimated $332K sold.

Nomura Holdings first reported a position in ADVM in Q1 2020 and held it in 4 quarters. The position peaked at $585K in Q1 2020. 92 funds tracked by Wall St. Rank hold ADVM as of Q1 2022.

  • Nomura Holdings reported no remaining Adverum Biotechnologies position as of Q1 2022 after selling out during the quarter.
  • Nomura Holdings sold 18,912 Adverum Biotechnologies shares in Q1 2022, an estimated $332K.
  • Nomura Holdings first reported a position in Adverum Biotechnologies in Q1 2020 and held it in 4 quarters.
  • Nomura Holdings's Adverum Biotechnologies position peaked at $585K in Q1 2020.
  • 92 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q1 2022.

Based on Nomura Holdings's 13F filing for Q1 2022, filed 18 May 2022.